DMCC SPECIALITY CHEMICALS profit and loss

Latest FY26

Revenue: ₹582cr+34.8% on FY25
EBITDA: ₹63.3cr+11.0% on FY25
Net profit: ₹27.3cr+26.9% on FY25
EPS: ₹10.96+27.0% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Sep 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Expenses
	854	582	431	328	385	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	0.9	1.0	1.3	10.4	4.9
	855	583	433	338	390
	680	411	259	196	260
	−13.5	−2.1	8.5	4.8	−11.8
	30.5	29.8	27.7	23.8	23.9
	13.0	9.6	10.5	13.8	10.6
	15.0	15.8	16.7	15.7	17.6
	79.0	79.8	79.0	67.6	79.0
	804	544	402	321	379
	77.9	63.3	57.0	36.3	33.9
	63.0	47.5	40.3	20.6	16.3
Profit
	50.8	39.0	31.1	17.3	10.6
	50.8	39.0	31.1	17.3	10.6
	9.4	6.8	5.2	3.0	1.9
	4.0	4.8	4.4	2.7	1.8
	13.4	11.6	9.6	5.7	3.7
	37.5	27.3	21.5	11.6	6.9
	37.5	27.3	21.5	11.6	6.9
	−0.6	−0.5	−1.1	−0.3	0.2
	36.9	26.8	20.4	11.3	7.1
	—	27.3	—	11.6	—
Per share
	₹15.01	₹10.96	₹8.63	₹4.65	₹8.57
	₹15.01	₹10.96	₹8.63	₹4.65	₹8.57
Other comprehensive income — detail
	−0.6	−0.5	−1.1	—	—
	−0.8	−0.4	−1.2	−0.3	0.3
	−0.1	0.2	−0.1	—	—
	—	—	—	−0.0	0.0
	0.0	0.1	—	0.0	−0.0
	0.0	0.0	−0.0	—	—
	—	—	—	11.3	7.1
Per share — as-filed variants
	₹15.01	₹10.96	₹8.63	₹4.65	₹8.57
	₹15.01	₹10.96	₹8.63	₹4.65	₹8.57
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	187	173	164	128	137
	21.9%	29.7%	38.0%	38.9%	35.6%
Adjusted (ex-exceptional items) — derived
	50.8	39.0	31.1	17.3	10.6
	37.5	27.3	21.5	11.6	6.9
	₹15.01	₹10.96	₹8.63	₹4.65	₹8.57

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

DMCC₹294.70

DMCC SPECIALITY CHEMICALS LIMITED

· Chemicals

Annual Quarterly₹ CrorePeersJAYAGROGN KRONOX SRHHYPOLTD GEMAROMA SUDARCOLOR CHEMFAB AMNPLST PRIMOMcap ₹735 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/09/2026
Revenue from Operations	384.7	328.0	431.3	581.6	854.4
Other Income	4.9	10.4	1.3	1.0	0.9
Total Income	389.6	338.4	432.6	582.6	855.3
Expenses
+ Cost of Materials Consumed	259.7	195.5	259.1	410.9	680.5
+ Changes in Inventories	-11.8	4.8	8.5	-2.1	-13.5
+ Employee Benefit Expense	23.9	23.8	27.7	29.8	30.5
+ Finance Costs	10.6	13.8	10.5	9.6	13.0
+ Depreciation & Amortisation	17.6	15.7	16.7	15.8	15.0
+ Other Expenses	79.0	67.6	79.0	79.8	79.0
Total Expenses	379.0	321.1	401.5	543.7	804.4
EBITDA	33.9	36.3	57.0	63.3	77.9
EBIT	16.3	20.6	40.3	47.5	63.0
Profit
PBT before Exceptional Items	10.6	17.3	31.1	39.0	50.8
Pretax Income	10.6	17.3	31.1	39.0	50.8
+ Current Tax	1.9	3.0	5.2	6.8	9.4
+ Deferred Tax	1.8	2.7	4.4	4.8	4.0
Tax Expense	3.7	5.7	9.6	11.6	13.4
Net Income	6.9	11.6	21.5	27.3	37.5
+ Net Income — Continuing Ops	6.9	11.6	21.5	27.3	37.5
+ Other Comprehensive Income	0.2	-0.3	-1.1	-0.5	-0.6
Total Comprehensive Income	7.1	11.3	20.4	26.8	36.9
Net Income to Common	—	11.6	—	27.3	—
Per Share
Basic EPS	8.57	4.65	8.63	10.96	15.01
Diluted EPS	8.57	4.65	8.63	10.96	15.01
Other Comprehensive Income — detail
+ Other Comprehensive Income	—	—	-1.1	-0.5	-0.6
+ Items NOT to be Reclassified to P&L	0.3	-0.3	-1.2	-0.4	-0.8
+ Tax on Items NOT to be Reclassified	—	—	-0.1	0.2	-0.1
+ Tax on Items NOT to be Reclassified — alt tag	0.0	-0.0	—	—	—
+ Items to be Reclassified to P&L	-0.0	0.0	—	0.1	0.0
+ Tax on Items to be Reclassified	—	—	-0.0	0.0	0.0
Comprehensive Income — Owners of Parent	7.1	11.3	—	—	—
Per Share — as-filed variants
Basic EPS — Continuing Operations	8.57	4.65	8.63	10.96	15.01
Diluted EPS — Continuing Operations	8.57	4.65	8.63	10.96	15.01
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	136.8	127.7	163.7	172.8	187.4
Gross Margin %	35.56	38.93	37.96	29.72	21.93
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	10.6	17.3	31.1	39.0	50.8
Net Income Adj (tax-effected)	6.9	11.6	21.5	27.3	37.5
EPS Adj	8.57	4.65	8.63	10.96	15.01
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	10.00	10.00	10.00	10.00	10.00
Paid Up Equity Capital	24.9	24.9	24.9	24.9	24.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.